Clinical trial

A Study of Zonisamide to Prevent Olanzapine-Associated Weight Gain

NCT00363376

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2008-01-01

PhasePHASE3

Study timeline

Study start (unknown)2008-01-01Date precision: month

Registry last updated2012-04-13

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Weight Gainunresolved

Interventions

zonisamideDRUG · verified · RxNorm: zonisamide

olanzapineDRUG · verified · RxNorm: olanzapine

ZonisamideDRUG · verified · RxNorm: zonisamide

Sugar Pill (placebo)DRUG

Sponsors & collaborators

Lindner Center of HOPElead sponsor

Eli Lilly and Companycollaborator

University of Cincinnaticollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00363376 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.